Search results
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 3 days agoLouis. Still, "if I'm a patient and I've failed all other kinds of therapies and someone offers me a...
InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and ...
Digital Journal· 2 days ago...First Open World Suspense Solo Player Game "Last Seen: Last Night" and Its Inaugural Shared IP Collaboration With Big M Entertainment Pictures Aemetis Selected to Join Russell 3000 Index ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Globe...
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on...
Digital Journal· 2 hours agoORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (Nasdaq:SNGX) and Sharps Technology Inc. (Nasdaq:STSS) on the RedChip Small Stocks, Big Money ...
Decoding HIV’s Defenses: Innovative Vaccine Strategy Shows Promise
SciTechDaily· 5 days agoResults from NIH-funded animal models will inform the development of vaccines for humans. Using...
ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update - ImmunityBio...
Benzinga· 2 hours agoImmunityBio, Inc. ((IBRX) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting ...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 3 hours agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 4 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 3 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoVirion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress PR Newswire PHILADELPHIA, June 5, 2024 Highlights from the Data
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 4 days agoOne of those prongs is improving immune responses, a pillar that stars Moderna-shared cancer vaccine...
